(COHR) Coherent - Overview
Stock: Transceivers, Laser, Materials, Optics, Subsystems
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 66.1% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.47 |
| Alpha | 110.33 |
| Character TTM | |
|---|---|
| Beta | 2.447 |
| Beta Downside | 2.407 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.85% |
| CAGR/Max DD | 1.29 |
Description: COHR Coherent December 19, 2025
Coherent Corp. (NYSE:COHR) designs, manufactures, and sells engineered materials, optoelectronic components, and laser systems that serve industrial, communications, electronics, and instrumentation markets worldwide. The business is organized into three segments: Networking (data-center transceivers, optics, and semiconductor devices), Materials (engineered ceramics, metal-matrix composites, and laser optics), and Lasers (excimer, solid-state, CO₂, and high-power lasers for semiconductor equipment, display and precision manufacturing, and scientific research). Sales are executed through a mix of direct forces, representatives, and distributors. The company, formerly II-VI Incorporated, rebranded to Coherent Corp. in September 2022 and is headquartered in Saxonburg, Pennsylvania.
Key recent metrics show FY 2023 revenue of roughly $1.3 billion, with the Laser segment posting a 12 % year-over-year growth driven by rising demand for high-power tools in semiconductor fab upgrades. Gross margins have stabilized near 45 %, and the firm generated about $150 million of free cash flow, supporting a modest dividend and share-repurchase program. Macro-level drivers include accelerating data-center traffic from AI workloads (boosting the Networking segment) and a global semiconductor cap-ex cycle that sustains laser-tool spend, while supply-chain tightness for semiconductor components remains a near-term risk.
For a deeper quantitative view, you might explore ValueRay’s detailed financial model for COHR.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 249.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.34 > 1.0 |
| NWC/Revenue: 38.16% < 20% (prev 45.42%; Δ -7.26% < -1%) |
| CFO/TA 0.04 > 3% & CFO 526.6m > Net Income 249.8m |
| Net Debt (2.65b) to EBITDA (1.21b): 2.20 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (155.5m) vs 12m ago 2.54% < -2% |
| Gross Margin: 36.01% > 18% (prev 0.32%; Δ 3569 % > 0.5%) |
| Asset Turnover: 41.11% > 50% (prev 34.03%; Δ 7.08% > 0%) |
| Interest Coverage Ratio: 1.82 > 6 (EBITDA TTM 1.21b / Interest Expense TTM 368.5m) |
Altman Z'' 2.60
| A: 0.16 (Total Current Assets 4.04b - Total Current Liabilities 1.74b) / Total Assets 14.70b |
| B: 0.05 (Retained Earnings 777.2m / Total Assets 14.70b) |
| C: 0.05 (EBIT TTM 669.3m / Avg Total Assets 14.70b) |
| D: 1.04 (Book Value of Equity 6.24b / Total Liabilities 6.01b) |
| Altman-Z'' Score: 2.60 = A |
Beneish M -3.85
| DSRI: 0.00 (Receivables 1.07b/819.71b, Revenue 6.04b/5.00b) |
| GMI: 0.89 (GM 36.01% / 32.17%) |
| AQI: 0.95 (AQ_t 0.59 / AQ_t-1 0.63) |
| SGI: 1.21 (Revenue 6.04b / 5.00b) |
| TATA: -0.02 (NI 249.8m - CFO 526.6m) / TA 14.70b) |
| Beneish M-Score: -3.85 (Cap -4..+1) = AAA |
What is the price of COHR shares?
Over the past week, the price has changed by -3.07%, over one month by +12.28%, over three months by +55.42% and over the past year by +132.23%.
Is COHR a buy, sell or hold?
- StrongBuy: 11
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the COHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 195.3 | -6.7% |
| Analysts Target Price | 195.3 | -6.7% |
| ValueRay Target Price | 275.8 | 31.8% |
COHR Fundamental Data Overview January 31, 2026
P/E Forward = 30.03
P/S = 5.6133
P/B = 5.8185
P/EG = 0.34
Revenue TTM = 6.04b USD
EBIT TTM = 669.3m USD
EBITDA TTM = 1.21b USD
Long Term Debt = 3.26b USD (from longTermDebt, last quarter)
Short Term Debt = 89.8m USD (from shortTermDebt, last quarter)
Debt = 3.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.65b USD (from netDebt column, last quarter)
Enterprise Value = 36.58b USD (33.92b + Debt 3.51b - CCE 852.8m)
Interest Coverage Ratio = 1.82 (Ebit TTM 669.3m / Interest Expense TTM 368.5m)
EV/FCF = 495.8x (Enterprise Value 36.58b / FCF TTM 73.8m)
FCF Yield = 0.20% (FCF TTM 73.8m / Enterprise Value 36.58b)
FCF Margin = 1.22% (FCF TTM 73.8m / Revenue TTM 6.04b)
Net Margin = 4.13% (Net Income TTM 249.8m / Revenue TTM 6.04b)
Gross Margin = 36.01% ((Revenue TTM 6.04b - Cost of Revenue TTM 3.87b) / Revenue TTM)
Gross Margin QoQ = 36.63% (prev 36.62%)
Tobins Q-Ratio = 2.49 (Enterprise Value 36.58b / Total Assets 14.70b)
Interest Expense / Debt = 1.67% (Interest Expense 58.7m / Debt 3.51b)
Taxrate = 21.0% (US default 21%)
NOPAT = 528.7m (EBIT 669.3m * (1 - 21.00%))
Current Ratio = 2.33 (Total Current Assets 4.04b / Total Current Liabilities 1.74b)
Debt / Equity = 0.42 (Debt 3.51b / totalStockholderEquity, last quarter 8.34b)
Debt / EBITDA = 2.20 (Net Debt 2.65b / EBITDA 1.21b)
Debt / FCF = 35.96 (Net Debt 2.65b / FCF TTM 73.8m)
Total Stockholder Equity = 7.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.70% (Net Income 249.8m / Total Assets 14.70b)
RoE = 3.14% (Net Income TTM 249.8m / Total Stockholder Equity 7.97b)
RoCE = 5.96% (EBIT 669.3m / Capital Employed (Equity 7.97b + L.T.Debt 3.26b))
RoIC = 5.78% (NOPAT 528.7m / Invested Capital 9.15b)
WACC = 13.66% (E(33.92b)/V(37.43b) * Re(14.93%) + D(3.51b)/V(37.43b) * Rd(1.67%) * (1-Tc(0.21)))
Discount Rate = 14.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.29%
[DCF Debug] Terminal Value 60.07% ; FCFF base≈93.6m ; Y1≈93.0m ; Y5≈97.3m
Fair Price DCF = N/A (negative equity: EV 816.8m - Net Debt 2.65b = -1.84b; debt exceeds intrinsic value)
EPS Correlation: -16.23 | EPS CAGR: -49.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 81.24 | Revenue CAGR: 19.66% | SUE: 1.83 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.32 | Chg30d=+0.010 | Revisions Net=+3 | Analysts=17
EPS current Year (2026-06-30): EPS=5.09 | Chg30d=+0.029 | Revisions Net=+3 | Growth EPS=+44.1% | Growth Revenue=+15.0%
EPS next Year (2027-06-30): EPS=6.34 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+24.7% | Growth Revenue=+14.9%